Call for older people to be vaccinated against pneumonia

May 14, 2018, University of New South Wales
Call for older people to be vaccinated against pneumonia
Credit: Shutterstock

Action is urgently needed to address declining vaccination rates against pneumococcal pneumonia, which causes more than 2,000 deaths each year in people aged over 65.

Researchers, doctors and patients have teamed with Lung Foundation Australia during this week's Pneumonia Awareness Week to call for proactive community action to address the declining  against pneumococcal – an infection responsible for more than 15,000 GP visits, 8,000 hospitalisations, and 2,000 deaths among those aged over 65 each year.

Their call coincides with an article published in MJA Insight today co-authored by Dr Rob Menzies of UNSW Medicine, which urges governments and doctors to work harder to reinforce the public health message regarding the seriousness of the potentially life-threatening but preventable infection, pneumococcal pneumonia.

The article reveals pneumonia ends lives prematurely, even in wealthy countries today with access to the best health care. It also reinforces that the main tools to prevent the most common cause of pneumonia – streptococcus pneumoniae, responsible for an estimated 20 per cent of pneumonia cases in Australia – are vaccines.

Dr Menzies says a healthcare professional's recommendation to vaccinate, or otherwise, is the most influential factor determining whether a person chooses to protect against vaccine preventable infections.

"We're achieving a 93 per cent pneumococcal vaccination rate among Australian children. Yet we're failing to achieve even a 50 per cent pneumococcal vaccination rate among equally vulnerable seniors, despite the publicly-funded immunisation program – a simple preventative health measure that could prevent serious disease or premature death," says Dr Menzies, of the UNSW Vaccine and Infection Research Lab.

"The most recent data suggest pneumococcal vaccination coverage has actually declined to 47 per cent in NSW, with more than half of these vaccinations occurring after 70 years of age.

"This decline must be urgently reversed. Doctors should be looking to opportunistically vaccinate those at risk of pneumococcal pneumonia (including people aged 65 and over, the immunocompromised and Indigenous Australians) in the same way they do for other population-based programs.

"It is also important for individuals to take the initiative for their own health. Anyone who smokes, has a chronic disease, immunocompromising condition, or is aged 65 years or over should talk to their GP about whether they should have a pneumococcal vaccination, or a re-vaccination against the infection," he says.

Associate Professor Lucy Morgan, Specialist Respiratory Physician and Lung Foundation Australia Respiratory Infectious Disease Committee Chair, Sydney, says all adults aged 65 years and over are at increased risk of contracting pneumococcal pneumonia due to their age alone, and many more have existing chronic medical conditions or lifestyle factors, such as current or past smoking, that places them at heightened risk of infection.

"Importantly, the MJA Insight article reinforces the importance of vaccination against pneumococcal pneumonia as a preventative health strategy from the age of 65, rather than delaying vaccination for a number of years.

"Given pneumonia is a potentially life-threatening respiratory , should an individual develop a cough, fever, shortness of breath, and feel generally tired and unwell, they should head to their doctor without delay," says Associate Professor Morgan.

The pneumococcal vaccine is provided free under the National Immunisation Program (NIP) Schedule for all Australians aged 65 and above, Indigenous Australians aged 50 years and over, Indigenous Australians aged 15 to 49 years who are medically at risk, and infants under 12 months.

A second dose of is also available to Australians with immunocompromising conditions or chronic disease, or smokers, a minimum of five years following their first dose.

Explore further: Many with work-related asthma not getting key vaccine

Related Stories

Many with work-related asthma not getting key vaccine

September 27, 2017
(HealthDay)—Only half of American adults with work-related asthma get the recommended vaccination against pneumococcal disease, a new study finds.

Pneumococcal rates plunge after widespread vaccination of infants

May 27, 2013
The number of young children contracting the most common strains of potentially fatal pneumococcal disease has plummeted 97% since the universal vaccination against this bacterial disease began in 2005, with unvaccinated ...

Study reveals new insight into susceptibility to pneumonia

May 3, 2017
A new research study of immune responses to pneumococcal vaccines, commonly given to people with compromised immune systems, young children and people over 65, has identified a type of immune cell which is important in generating ...

RSV infection may be associated with higher risk for bacterial pneumonia

January 6, 2015
Two common and sometimes dangerous respiratory diseases, a viral one caused by respiratory syncytial virus (RSV), and a bacterial one caused by Streptococcus pneumoniae may be linked, suggests a study published in this week's ...

Seniors need two pneumonia vaccines, CDC advisory panel says

February 3, 2015
(HealthDay)—Adults 65 and older need two vaccines to better protect them from bacterial infection in the blood (called sepsis), meningitis and pneumonia, according to a revised vaccination schedule from the 2015 Advisory ...

Fresh hope for preventing pneumonia in the elderly

April 24, 2014
There are calls for the frail and elderly not be be overlooked for vaccines against pneumonia this winter, with UNSW research challenging conventional wisdom on immunisation effectiveness in older patients.

Recommended for you

Growing kidney tissue simpler and faster will help fight disease

July 23, 2018
New treatments for kidney diseases and inherited kidney disorders could result from new research that is revolutionising the way human kidney tissue is grown from stem cells.

Yeast species used in food industry causes disease in humans

July 19, 2018
A major cause of drug-resistant clinical yeast infections is the same species previously regarded as non-pathogenic and commonly used in the biotechnology and food industries. The study, published on July 19th in the open-access ...

Deadly Rift Valley fever: New insight, and hope for the future

July 19, 2018
Health control measures alone could be ineffective in the long term fight against the deadly Rift Valley fever which affects both humans and animals, a new study in the journal PNAS reports.

New guidelines to diagnose, manage rare endocrine disorders

July 19, 2018
International guidelines have been published for the first time to help doctors around the globe diagnose and manage patients with a very rare set of endocrine diseases known as pseudohypoparathyroidism and its related disorders, ...

Overuse of antibiotics not what the doctor ordered

July 19, 2018
With increased use of antibiotics worldwide linked to growing antibiotic resistance, a world-first study co-authored by a QUT researcher has highlighted the growing impact of non-prescription supply of antibiotics in community ...

Alcohol-related cirrhosis deaths skyrocket in young adults

July 18, 2018
Deaths from cirrhosis rose in all but one state between 1999-2016, with increases seen most often among young adults, a new study shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.